HejuruUbuyobozi bukurikira
Intego ya AI Kumenyekanisha Ibiyobyabwenge
Inganda
UBUYOBOZI
AI methods can support several stages of drug research, including protein-structure prediction, molecular property prediction, virtual screening and molecule generation.
Umva iki gitaboAI-byavuzwe · ~2 min
A model result is a research hypothesis or prioritization signal, not evidence of clinical safety or efficacy.
AlphaFold predicts protein structures, while AlphaFold 3 extends structure prediction to biomolecular complexes involving proteins, nucleic acids, small molecules and other components. MoleculeNet describes machine-learning tasks over molecular representations including graphs and SMILES. Deep Docking illustrates one virtual-screening approach that uses predictions to reduce how many compounds require expensive docking calculations. DeepTox and later molecular-generation studies address toxicity prediction and candidate generation; these methods do not establish a compound’s safety, efficacy or clinical success. FDA describes preclinical testing and an IND process before clinical studies in people.
Using AlphaFold to predict protein structures, as reported in its paper and resource database.
Using AlphaFold 3 to predict structures and interactions among proteins, nucleic acids, small molecules and other biomolecules.
Representing molecules as graphs or SMILES strings in molecular-learning benchmarks.
Using virtual screening to prioritize compounds for experimental testing, with predictions treated as uncertain.
Evaluate screening and generation methods on prospective, target-relevant data and report experimental confirmation rates. Follow regulatory requirements for preclinical and human research; remove candidates only after evidence appropriate to the task, rather than treating model scores as final decisions.
Ibaruwa y'amakuru y'ubuntu
Inkuru eshatu zizewe za AI buri gitondo cy'iminsi y'akazi, zanditse mu rurimi rworoshye. Ubuntu iteka ryose, nta kwamamaza.
Imeri imwe buri munsi y'akazi. Kwiyimura mu buryo bumwe. Ntitwigera tugurisha cyangwa ngo dusangire aderesi yawe.
Isuzume
Ibisubizo ako kanya kuri buri kibazo, n'icyemezo gishobora gusangirwa gifite ID yagenzurwa umaze gutsinda isomo.
Fasha uburezi bwa AI bw'ubuntu. AI Understanding ni umuryango utegamiye kuri leta wa 501(c)(3) — nta kwamamaza, nta kwishyura, iteka ryose. Tanga impano
AI methods can support several stages of drug research, including protein-structure prediction, molecular property prediction, virtual screening and molecule generation. A model result is a research hypothesis or prioritization signal, not evidence of clinical safety or efficacy.
AlphaFold yakoresheje kwiga byimbitse guhanura poroteyine ya 3D ku gipimo, iha abashakashatsi igishushanyo mbonera cyafashe imyaka myinshi y'ubushakashatsi.
Molekile ni ibishushanyo bisanzwe (atome = node, bonds = impande) bitunganijwe nimbonerahamwe ya neural net, cyangwa ikabikwa nka SMILES imirongo ya moderi ikurikirana.
Isuzuma rya Virtual rikoresha moderi kugirango utange amasomero manini ya molekile muri silico, bityo abakandida bambere bonyine barakozwe kandi bapimwe muri laboratoire.
Computational ADME/toxicity predictions can prioritize compounds for follow-up; they are model outputs and do not establish safety or replace experimental testing.
Moderi yibyara nka VAEs hamwe na diffuzion moderi yerekana ibyubaka bishya bivuye mumwanya wize wize, ugahitamo kubintu byifuzwa.
Komeza wige
Abandi bayobozi batoranijwe kuriyi ngingo
HejuruUbuyobozi bukurikira
Intego ya AI Kumenyekanisha Ibiyobyabwenge
Inganda